NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

大麻製劑的全球市場 - 市場佔有率·市場規模·趨勢·產業分析報告:產品 ·流通管道·地區·各市場區隔的預測 (2020∼2027年)

Cannabis Pharmaceuticals Market Share, Size, Trends, Industry Analysis Report, By Product (Epidiolex, Marinol, Cesamet, Sativex); By Distribution Channel; By Regions; Segment Forecast, 2020 - 2027

出版商 Polaris Market Research 商品編碼 986414
出版日期 內容資訊 英文 104 Pages
商品交期: 最快1-2個工作天內
價格
大麻製劑的全球市場 - 市場佔有率·市場規模·趨勢·產業分析報告:產品 ·流通管道·地區·各市場區隔的預測 (2020∼2027年) Cannabis Pharmaceuticals Market Share, Size, Trends, Industry Analysis Report, By Product (Epidiolex, Marinol, Cesamet, Sativex); By Distribution Channel; By Regions; Segment Forecast, 2020 - 2027
出版日期: 2020年12月01日內容資訊: 英文 104 Pages
簡介

全球大麻製劑的市場規模在2027年前將達到57億2000萬美元。

本報告提供全球大麻製劑市場相關調查,提供市場概要與趨勢,各市場區隔·各地區的趨勢分析與市場佔有率,競爭情形,並提供主要企業簡介等資訊。

目錄

第1章 簡介

  • 報告的說明
    • 調查目的
    • 市場範圍
    • 前提條件
  • 相關利益者

第2章 摘要整理

  • 市場亮點

第3章 調查手法

  • 概要
    • 資料探勘
  • 資料來源
    • 主要資源
    • 次要來源

第4章 大麻製劑市場考察

  • 產業的概述
  • 市場動態
    • 推動要素和機會
    • 阻礙因素與課題
  • 波特的五力分析
    • 供給企業談判力(中)
    • 新加入廠商者的威脅:(低)
    • 買方議價能力(中)
    • 替代威脅(中)
    • 現有企業間的競爭(量)
  • 大環境分析
  • 產業趨勢

第5章 大麻製劑的市場評估:各產品

  • 主要調查結果
  • 簡介
    • 全球大麻製劑市場:各產品 (以金額為準)
  • Sativex
    • 全球大麻製劑市場:Sativex - 各地區 (以金額為準)
  • Epidiolex
    • 全球大麻製劑市場:Epidiolex - 各地區 (以金額為準)
  • Marinol
    • 全球大麻製劑市場:Marinol - 各地區 (以金額為準)
  • Cesamet
    • 全球大麻醫藥品市場:Cesamet - 各地區 (以金額為準)

第6章 大麻製劑的市場評估:各流通管道

  • 主要調查結果
  • 簡介
    • 全球大麻製劑市場:各流通管道 (以金額為準)
  • 醫院藥局
    • 全球大麻製劑市場:醫院藥局 - 各地區 (以金額為準)
  • 線上藥局
    • 全球大麻製劑市場:線上藥局 - 各地區 (以金額為準)
  • 零售藥局
    • 全球大麻製劑市場:零售藥局 - 各地區 (以金額為準)

第7章 大麻製劑的市場評估:各地區

  • 主要調查結果
  • 簡介
    • 大麻製劑市場評估:各地區 (以金額為準)
  • 北美市場
    • 各產品 (以金額為準)
    • 各流通管道 (以金額為準)
    • 美國
    • 加拿大
  • 歐洲市場
    • 各產品 (以金額為準)
    • 各流通管道 (以金額為準)
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 奧地利
  • 亞太地區市場
    • 各產品 (以金額為準)
    • 各流通管道 (以金額為準)
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
  • 中東·非洲市場
    • 各產品 (以金額為準)
    • 各流通管道 (以金額為準)
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
  • 南美市場
    • 各產品 (以金額為準)
    • 各流通管道 (以金額為準)
    • 墨西哥
    • 巴西
    • 阿根廷

第8章 競爭情形

  • 擴張與收購分析
    • 擴張
    • 收購
  • 夥伴關係/合作/契約/展示會

第9章 企業簡介

  • GW Pharmaceuticals
  • Valeant Pharmaceuticals
  • Insys Therapeutics, Inc.
  • Corbus Pharmaceuticals
  • Teva Pharmaceutical
  • Avicanna
  • Solvay Pharmaceuticals
  • Sprint Corporation
  • Cannabics Pharmaceuticals
  • Kao Corporation
目錄
Product Code: PM1773

The global cannabis pharmaceuticals market is expected to reach USD 5.72 billion by 2027, according to a new study by Polaris Market Research. The report "Cannabis Pharmaceuticals Market Share, Size, Trends, Industry Analysis Report, By Product (Epidiolex, Marinol, Cesamet and Sativex); By Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies), By Regions; Segment Forecast, 2020 - 2027" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Favorable legislation in the market, policies across developed economies, and investments in the research and development for cannabis-infused drugs are the key factors responsible for the market growth. Moreover, technological innovation to decide the accurate dose of cannabis-infused drugs with cutting edge delivery methods to ensure therapeutic and psychoactive events, to contain drug abuse among adults also favoring market growth for cannabis pharmaceuticals. Blockchain technology in the pharmaceutical industry could be used to maintain strain purity and product formulations to have effective treatment for the therapeutic cause and will also enable us to capture dosage data for future considerations, thus technology could also play important role in shaping the market future of the cannabis pharmaceuticals industry.

The global market for cannabis pharmaceuticals is fragmented based on product, distribution channel, and region. In terms of product, the market is segmented into Epidiolex, Marinol, Cesamet, and Sativex. Based on distribution channel, the cannabis pharmaceuticals industry is further bifurcated into hospital, online, and retail pharmacies.

Segment Highlights

Sativex segment accounted for the largest revenue share in 2019 owing to the growing usage of drug for the muscle spasticity. In addition, growing demand for plant-based pharmaceuticals is expected to drive market demand for cannabis pharmaceuticals.

Based on distribution channel, the hospitals pharmacies segment is projected to account for a significant share by 2027. The high share is attributed to the fact that most of the physicians recommend medicines from in-house pharmacy stores driving the cannabis medicines market growth.

Europe accounted for the largest share in 2019 in terms of revenue on account of the increasing demand for plant-based medicines and the increasing awareness pertaining to the medicinal benefits associated cannabis

List of Key Players:

GW Pharmaceuticals

Valeant Pharmaceuticals

Insys Therapeutics, Inc.

Corbus Pharmaceuticals

Teva Pharmaceutical

Avicanna

Solvay Pharmaceuticals

Cannabics Pharmaceuticals

Others

Polaris Market Research has segmented the cannabis pharmaceuticals market report on the basis of product, distribution channel, and region

Cannabis Pharmaceuticals, Product Outlook (Revenue - USD Million, 2016 - 2027)

Sativex

Marinol

Cesamet

Epidiolex

Cannabis Pharmaceuticals, Distribution Channel Outlook (Revenue - USD Million, 2016 - 2027)

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Cannabis Pharmaceuticals, Regional Outlook (Revenue - USD Million, 2016 - 2027)

North America

U.S.

Canada

Europe

France

Germany

UK

Italy

Spain

Netherlands

Austria

Asia Pacific

China

India

Japan

Malaysia

South Korea

Indonesia

Central & South America

Mexico

Brazil

Argentina

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Cannabis Pharmaceuticals Market Insights

  • 4.1. Cannabis Pharmaceuticals - Industry snapshot
  • 4.2. Cannabis Pharmaceuticals Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increased use in different therapeutic areas
      • 4.2.1.2. Increased support in the form of clinical evidence
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Shelf life of cannabidiol and cross reactions
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Cannabis Pharmaceuticals Market Industry trends

5. Cannabis Pharmaceuticals Market Assessment by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • 5.3. Sativex
    • 5.3.1. Global Cannabis Pharmaceuticals Market, by Sativex, by Region, 2016 - 2027 (USD Million)
  • 5.4. Epidiolex
    • 5.4.1. Global Cannabis Pharmaceuticals Market, by Epidiolex, by Region, 2016 - 2027 (USD Million)
  • 5.5. Marinol
    • 5.5.1. Global Cannabis Pharmaceuticals Market, by Marinol, by Region, 2016 - 2027 (USD Million)
  • 5.6. Cesamet
    • 5.6.1. Global Cannabis Pharmaceuticals Market, by Cesamet, by Region, 2016 - 2027 (USD Million)

6. Global Cannabis Pharmaceuticals Market, by Distribution Channel

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • 6.3. Hospital Pharmacies
    • 6.3.1. Global Cannabis Pharmaceuticals Market, by Hospital Pharmacies, By Region, 2016 - 2027 (USD Million)
  • 6.4. Online Pharmacies
    • 6.4.1. Global Cannabis Pharmaceuticals Market, by Online Pharmacies, by Region, 2016 - 2027 (USD Million)
  • 6.5. Retail Pharmacies
    • 6.5.1. Global Cannabis Pharmaceuticals Market, by Retail Pharmacies, by Region, 2016 - 2027 (USD Million)

7. Cannabis Pharmaceuticals Market Assessment by Geography

  • 7.1. Key findings
  • 7.2. Introduction
    • 7.2.1. Cannabis Pharmaceuticals Market Assessment, By Geography, 2016 - 2027 (USD Million)
  • 7.3. Cannabis Pharmaceuticals Market - North America
    • 7.3.1. North America: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
    • 7.3.2. North America: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 7.3.3. Cannabis Pharmaceuticals Market - U.S.
      • 7.3.3.1. U.S.: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
      • 7.3.3.2. U.S.: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 7.3.4. Cannabis Pharmaceuticals Market - Canada
      • 7.3.4.1. Canada: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
      • 7.3.4.2. Canada.: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • 7.4. Cannabis Pharmaceuticals Market - Europe
    • 7.4.1. Europe: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
    • 7.4.2. Europe: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 7.4.3. Cannabis Pharmaceuticals Market - UK
      • 7.4.3.1. UK: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
      • 7.4.3.2. UK: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 7.4.4. Cannabis Pharmaceuticals Market - France
      • 7.4.4.1. France: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
      • 7.4.4.2. France: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 7.4.5. Cannabis Pharmaceuticals Market - Germany
      • 7.4.5.1. Germany: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
      • 7.4.5.2. Germany: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 7.4.6. Cannabis Pharmaceuticals Market - Italy
      • 7.4.6.1. Italy: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
      • 7.4.6.2. Italy: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 7.4.7. Cannabis Pharmaceuticals Market - Spain
      • 7.4.7.1. Spain: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
      • 7.4.7.2. Spain: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 7.4.8. Cannabis Pharmaceuticals Market - Netherlands
      • 7.4.8.1. Netherlands: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
      • 7.4.8.2. Netherlands: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 7.4.9. Cannabis Pharmaceuticals Market - Austria
      • 7.4.9.1. Austria: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
      • 7.4.9.2. Austria: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • 7.5. Cannabis Pharmaceuticals Market - Asia-Pacific
    • 7.5.1. Asia Pacific: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
    • 7.5.2. Asia Pacific: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 7.5.3. Cannabis Pharmaceuticals Market - China
      • 7.5.3.1. China: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
      • 7.5.3.2. China: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 7.5.4. Cannabis Pharmaceuticals Market - India
      • 7.5.4.1. India: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
      • 7.5.4.2. India.: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 7.5.5. Cannabis Pharmaceuticals Market - Malaysia
      • 7.5.5.1. Malaysia: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
      • 7.5.5.2. Malaysia: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 7.5.6. Cannabis Pharmaceuticals Market - Japan
      • 7.5.6.1. Japan: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
      • 7.5.6.2. Japan: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 7.5.7. Cannabis Pharmaceuticals Market - Indonesia
      • 7.5.7.1. Indonesia: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
      • 7.5.7.2. Indonesia: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 7.5.8. Cannabis Pharmaceuticals Market - South Korea
      • 7.5.8.1. South Korea: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
      • 7.5.8.2. South Korea.: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • 7.6. Cannabis Pharmaceuticals Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
    • 7.6.2. Middle East & Africa.: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 7.6.3. Cannabis Pharmaceuticals Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
      • 7.6.3.2. Saudi Arabia.: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 7.6.4. Cannabis Pharmaceuticals Market - UAE
      • 7.6.4.1. UAE: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
      • 7.6.4.2. UAE: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 7.6.5. Cannabis Pharmaceuticals Market - Israel
      • 7.6.5.1. Israel: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
      • 7.6.5.2. Israel: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 7.6.6. Cannabis Pharmaceuticals Market - South Africa
      • 7.6.6.1. South Africa: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
      • 7.6.6.2. South Africa: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • 7.7. Cannabis Pharmaceuticals Market - Latin America
    • 7.7.1. Latin America: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
    • 7.7.2. Latin America: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 7.7.3. Cannabis Pharmaceuticals Market - Mexico
      • 7.7.3.1. Mexico: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
      • 7.7.3.2. Mexico.: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 7.7.4. Cannabis Pharmaceuticals Market - Brazil
      • 7.7.4.1. Brazil: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
      • 7.7.4.2. Brazil.: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 7.7.5. Cannabis Pharmaceuticals Market - Argentina
      • 7.7.5.1. Argentina: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
      • 7.7.5.2. Argentina.: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisition
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. GW Pharmaceuticals
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Valeant Pharmaceuticals
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Insys Therapeutics, Inc.
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Corbus Pharmaceuticals
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Teva Pharmaceutical
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Avicanna
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. Solvay Pharmaceuticals
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Sprint Corporation
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Cannabics Pharmaceuticals
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. Kao Corporation
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development

List of Tables

  • Table 1 Global Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 2 Global Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 3 Cannabis Pharmaceuticals Market Assessment, By Geography, 2016 - 2027 (USD Million)
  • Table 4 North America: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 5 North America: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 6 U.S.: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 7 U.S.: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 8 Canada: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 9 Canada: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 10 Europe: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 11 Europe: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 12 UK: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 13 UK: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 14 France: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 15 France: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 16 Germany: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 17 Germany: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 18 Italy: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 19 Italy: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 20 Spain: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 21 Spain: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 22 Netherlands: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 23 Netherlands: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 24 Austria: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 25 Austria: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 26 Asia Pacific: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 27 Asia Pacific: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 28 China: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 29 China: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 30 India: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 31 India: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 32 Malaysia: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 33 Malaysia: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 34 Japan: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 35 Japan: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 36 Indonesia: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 37 Indonesia: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 38 South Korea: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 39 South Korea: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 40 Middle East & Africa: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 41 Middle East & Africa: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 42 Saudi Arabia: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 43 Saudi Arabia: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 44 UAE: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 45 UAE: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 46 Israel: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 47 Israel: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 48 South Africa: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 49 South Africa: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 50 Latin America: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 51 Latin America: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 52 Mexico: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 53 Mexico: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 54 Brazil: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 55 Brazil: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 56 Argentina: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 57 Argentina: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)

List of Figures

Figure 1 Market Highlights (2019, Revenue)

Figure 2 Integrated Ecosystem

Figure 3 Research Methodology: Top Down & Bottom Up Approach

Figure 4 Market by Geography

Figure 5 Porter's Five Forces

Figure 6 Market by Product

Figure 7 Global Cannabis Pharmaceuticals Market, By Product, 2019 & 2027 (USD Million)

Figure 8 Market by Distribution Channel

Figure 9 Global Cannabis Pharmaceuticals Market, By Distribution Channel, 2019 & 2027 (USD Million)

Figure 10 Cannabis Pharmaceuticals Market Assessment, By Geography, 2016 - 2027 (USD Million)

Figure 11 Strategic Analysis - Cannabis Pharmaceuticals Market